ALZA: Clinical Trials

4 trials sponsored by ALZA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 unknown. 2 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 1, Unknown 1
Phase 31Terminated 1

Follow ALZA: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of S-CKD602 in Patients With Advanced Malignancies
S CKD602 - Cancer
Phase 1CompletedUniversity of Pittsburgh452003-09-012013-12-19
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
amifostine trihydrate, cytarabine, topotecan hydrochloride - Leukemia, Myelodysplastic Syndromes
Phase 2UnknownALZA251999-01-012013-12-04
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
amifostine trihydrate, irinotecan hydrochloride - Colorectal Cancer
Phase 1 / Phase 2CompletedJonsson Comprehensive Cancer Center231997-07-012020-08-03
CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
CAELYX, Paclitaxel HCl - Ovarian Neoplasms
Phase 3TerminatedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.2201997-05-012010-04-27

Conditions studied

Anemia, Refractory, with Excess of Blasts (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Leukemia (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Rectal Neoplasms (1)

Interventions

Amifostine (2)  ·  Cytarabine (1)  ·  Irinotecan (1)  ·  Topotecan (1)  ·  liposomal doxorubicin (1)

Countries

United States (3)

Top investigators

Diane Prager, MD (1)  ·  Henry C. Fung, MD, FRCPE (1)  ·  Ramesh K Ramanathan, MD (1)